|
Our businesses combine skills in understanding genetic
predisposition and the molecular basis of disease, with skills for
screening for the onset of disease. Being part of the same
company allows us to share our knowledge and explore how our
complementary skills may help to discover new and better ways
of predicting, preventing and monitoring disease.
Looking further ahead, our leading global presence in genetics,
proteomics and diagnostics is the platform on which most of
the future of personalised medicine will be built. We are well
placed to benefit from what we believe will be substantial new
market opportunities in the rapidly changing world of medicine.
|
